共 266 条
[11]
Coats DK(1996)Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity Arch Ophthalmol 114 1219-1228
[12]
Repka MX(1997)Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization Am J Pathol 151 281-291
[13]
Tung BMS(2004)Variable oxygen and retinal VEGF levels: correlation with incidence with and severity of pathology in a rat model of oxygen-induced retinopathy Exp Eye Res 79 623-630
[14]
Good W(1996)Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity Invest Ophthalmol Vis Sci 37 290-299
[15]
Gilbert WS(2004)The role of VEGF and IGF-1 in a hypercarbic oxygen-induced retinopathy rat model of ROP Mol Vis 10 43-50
[16]
Quinn GE(2006)Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage Retina 26 275-278
[17]
Dobson V(2006)Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration Ophthalmology 113 363-372
[18]
Reynolds J(2005)The International Classification of Retinopathy of Prematurity revisited Arch Ophthalmol 123 991-999
[19]
Hardy RJ(2003)Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial Arch Ophthalmol 121 1684-1694
[20]
Palmer EA(2004)Multicenter trial of early treatment for retinopathy of prematurity: study design Control Clin Trials 25 311e25-1730